Dowd Joseph P
VP, Zero Harm at KOP
- Sold, on record
- $3.9M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Aug 19, 2024
- Form 144 notices
- 9
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- KOPKoppers Holdings Inc.VP, Zero Harm
Sales by reason
0
Routine
3
Plan not stated
3
No plan
6
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Aug 19, 2024Unusual
Sold 34.9% of their holdings
$208k5,516 shares at $37.72
- Aug 19, 2024Notice
Filed a notice to sell 5,516 shares
$208k5,516 shares
- May 17, 2024Unusual
Sold 27.5% of their holdings
$267k6,000 shares at $44.46
- May 17, 2024Notice
Filed a notice to sell 6,000 shares
$267k6,000 shares
- Mar 6, 2024No plan
Sold 5.6% of their holdings
$68k1,300 shares at $52.32
- Mar 6, 2024Notice
Filed a notice to sell 1,300 shares
$68k1,300 shares
- Mar 5, 2024Unusual
Sold 43% of their holdings
$931k17,385 shares at $53.53
- Mar 5, 2024Notice
Filed a notice to sell 13,897 shares
$744k13,897 shares
- Mar 4, 2024Notice
Filed a notice to sell 3,488 shares
$187k3,488 shares
- Mar 1, 2024Unusual
Sold 28.2% of their holdings
$774k14,500 shares at $53.38
10 of 21
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Aug 20, 2024 | KOP | VP, Zero Harm | Sold | 5,516 | $37.72 | $208k | 10,300 | SEC |
| May 17, 2024 | May 17, 2024 | KOP | VP, Zero Harm | Sold | 6,000 | $44.46 | $267k | 15,792 | SEC |
| Mar 6, 2024 | Mar 7, 2024 | KOP | VP, Zero Harm | Sold | 1,300 | $52.32 | $68k | 21,772 | SEC |
| Mar 5, 2024 | Mar 6, 2024 | KOP | VP, Zero Harm | Sold | 17,385 | $53.53 | $931k | 23,072 | SEC |
| Mar 4, 2024 | Mar 6, 2024 | KOP | VP, Zero Harm | Exercised or settledEmployee Stock Options (Rights to Buy) | 3,488 | 0 | SEC | ||
| Mar 4, 2024 | Mar 6, 2024 | KOP | VP, Zero Harm | Exercised options | 3,488 | $34.92 | $122k | 38,685 | SEC |
| Mar 1, 2024 | Mar 5, 2024 | KOP | VP, Zero Harm | Sold | 14,500 | $53.38 | $774k | 36,969 | SEC |
| Mar 1, 2024 | Mar 5, 2024 | KOP | VP, Zero Harm | Exercised or settledDividend Equivalent Rights | 14,039 | 1,716 | SEC | ||
| Mar 1, 2024 | Mar 5, 2024 | KOP | VP, Zero Harm | Exercised options | 14,039 | $36.01 | $505k | 43,268 | SEC |
| Mar 1, 2024 | Mar 5, 2024 | KOP | VP, Zero Harm | Withheld for tax | 800 | $52.97 | $42k | 37,455 | SEC |
| Jan 5, 2024 | Jan 8, 2024 | KOP | VP, Zero Harm | Exercised or settledRestricted Stock Units | 4,740 | 132 | SEC | ||
| Jan 5, 2024 | Jan 8, 2024 | KOP | VP, Zero Harm | Exercised options | 4,740 | 42,115 | SEC | ||
| Jan 5, 2024 | Jan 8, 2024 | KOP | VP, Zero Harm | Withheld for tax | 3,885 | $47.32 | $184k | 38,230 | SEC |
| Jan 4, 2024 | Jan 8, 2024 | KOP | VP, Zero Harm | AwardedRestricted Stock Units | 6,130 | 230 | SEC | ||
| Jan 4, 2024 | Jan 8, 2024 | KOP | VP, Zero Harm | Awarded | 2,211 | 37,375 | SEC | ||
| Dec 14, 2023 | Dec 15, 2023 | KOP | VP, Zero Harm | Sold | 2,600 | $45.33 | $118k | 35,142 | SEC |
| Dec 12, 2023 | Dec 14, 2023 | KOP | VP, Zero Harm | AwardedDividend Equivalent Rights | 85 | 159 | SEC | ||
| Nov 17, 2023 | Nov 20, 2023 | KOP | VP, Zero Harm | Sold | 5,250 | $42.46 | $223k | 37,742 | SEC |
| Nov 17, 2023 | Nov 20, 2023 | KOP | VP, Zero Harm | Exercised or settledEmployee Stock Options (Rights to Buy) | 5,250 | 0 | SEC | ||
| Nov 17, 2023 | Nov 20, 2023 | KOP | VP, Zero Harm | Exercised options | 5,250 | $37.93 | $199k | 42,992 | SEC |
| Jun 6, 2023 | Jun 8, 2023 | KOP | Global VP, Zero Harm | Sold | 15,265 | $31.42 | $480k | 37,688 | SEC |
| Jun 6, 2023 | Jun 8, 2023 | KOP | Global VP, Zero Harm | Exercised or settledEmployee Stock Options (Rights to Buy) | 15,265 | 0 | SEC | ||
| Jun 6, 2023 | Jun 8, 2023 | KOP | Global VP, Zero Harm | Exercised options | 15,265 | $17.96 | $274k | 52,953 | SEC |
| Mar 6, 2023 | Mar 7, 2023 | KOP | Global VP, Zero Harm | Exercised or settledDividend Equivalent Rights | 16 | 74 | SEC | ||
| Mar 6, 2023 | Mar 7, 2023 | KOP | Global VP, Zero Harm | Exercised options | 16 | 37,820 | SEC | ||
| Mar 6, 2023 | Mar 7, 2023 | KOP | Global VP, Zero Harm | Withheld for tax | 982 | $37.20 | $37k | 37,655 | SEC |
| Jan 5, 2023 | Jan 9, 2023 | KOP | Global VP, Zero Harm | Exercised or settledDividend Equivalent Rights | 17 | 81 | SEC | ||
| Jan 5, 2023 | Jan 9, 2023 | KOP | Global VP, Zero Harm | Exercised options | 17 | 39,738 | SEC | ||
| Jan 5, 2023 | Jan 9, 2023 | KOP | Global VP, Zero Harm | Withheld for tax | 1,116 | $28.58 | $32k | 38,622 | SEC |
| Jan 5, 2023 | Jan 9, 2023 | KOP | Global VP, Zero Harm | AwardedRestricted Stock Units | 1,480 | 90 | SEC | ||
| Jan 4, 2023 | Jan 5, 2023 | KOP | Global VP, Zero Harm | Awarded | 3,567 | 39,684 | SEC | ||
| Jan 3, 2023 | Jan 5, 2023 | KOP | Global VP, Zero Harm | AwardedDividend Equivalent Rights | 98 | 98 | SEC | ||
| Mar 4, 2022 | Mar 8, 2022 | KOP | Global VP, Zero Harm | Exercised or settledRestricted Stock Units | 9,745 | 0 | SEC | ||
| Mar 4, 2022 | Mar 8, 2022 | KOP | Global VP, Zero Harm | Exercised options | 9,745 | 40,567 | SEC | ||
| Mar 4, 2022 | Mar 8, 2022 | KOP | Global VP, Zero Harm | Withheld for tax | 4,564 | $28.18 | $129k | 36,003 | SEC |
| Mar 3, 2022 | Mar 7, 2022 | KOP | Global VP, Zero Harm | Withheld for tax | 821 | $28.96 | $24k | 30,822 | SEC |
| Mar 2, 2022 | Mar 4, 2022 | KOP | Global VP, Zero Harm | Withheld for tax | 108 | $28.49 | $3k | 31,643 | SEC |
| Feb 28, 2022 | Mar 2, 2022 | KOP | Global VP, Zero Harm | Sold | 1,749 | $28.75 | $50k | 31,751 | SEC |
| Feb 28, 2022 | Mar 1, 2022 | KOP | Global VP, Zero Harm | Sold | 3,000 | $28.51 | $86k | 33,500 | SEC |
| Jan 5, 2022 | Jan 7, 2022 | KOP | Global VP, Zero Harm | Withheld for tax | 439 | $33.27 | $15k | 36,475 | SEC |
| Jan 5, 2022 | Jan 7, 2022 | KOP | Global VP, Zero Harm | AwardedRestricted Stock Units | 3,831 | 1,312 | SEC | ||
| Jan 4, 2022 | Jan 6, 2022 | KOP | Global VP, Zero Harm | Awarded | 4,636 | 36,914 | SEC | ||
| Mar 6, 2021 | Mar 9, 2021 | KOP | Global VP, Zero Harm | Withheld for tax | 166 | $35.45 | $6k | 31,700 | SEC |
| Mar 3, 2021 | Mar 5, 2021 | KOP | Global VP, Zero Harm | Exercised or settledRestricted Stock Units | 322 | 0 | SEC | ||
| Mar 3, 2021 | Mar 5, 2021 | KOP | Global VP, Zero Harm | Exercised options | 322 | 32,897 | SEC | ||
| Mar 3, 2021 | Mar 5, 2021 | KOP | Global VP, Zero Harm | Withheld for tax | 1,031 | $35.72 | $37k | 31,866 | SEC |
| Mar 2, 2021 | Mar 4, 2021 | KOP | Global VP, Zero Harm | Withheld for tax | 112 | $34.87 | $4k | 32,575 | SEC |
| Feb 16, 2021 | Feb 18, 2021 | KOP | Global VP, Zero Harm | AwardedRestricted Stock Units | 3,556 | 3,556 | SEC | ||
| Jan 4, 2021 | Jan 6, 2021 | KOP | Global VP, Zero Harm | Awarded | 4,901 | 32,687 | SEC | ||
| Mar 6, 2020 | Mar 10, 2020 | KOP | Global VP, Zero Harm | Withheld for tax | 136 | $18.41 | $3k | 26,730 | SEC |
Page 1
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Aug 20, 2024 | KOP | VP, Zero Harm | Form 4 sale | 5,516 | $208k | 34.9% | Unusual | SEC |
| Aug 19, 2024 | Aug 19, 2024 | KOP | VP, Zero Harm | Form 144 notice | 5,516 | $208k | Notice | SEC | |
| May 17, 2024 | May 17, 2024 | KOP | VP, Zero Harm | Form 4 sale | 6,000 | $267k | 27.5% | Unusual | SEC |
| May 17, 2024 | May 17, 2024 | KOP | VP, Zero Harm | Form 144 notice | 6,000 | $267k | Notice | SEC | |
| Mar 6, 2024 | Mar 7, 2024 | KOP | VP, Zero Harm | Form 4 sale | 1,300 | $68k | 5.6% | No plan | SEC |
| Mar 6, 2024 | Mar 6, 2024 | KOP | VP, Zero Harm | Form 144 notice | 1,300 | $68k | Notice | SEC | |
| Mar 5, 2024 | Mar 6, 2024 | KOP | VP, Zero Harm | Form 4 sale | 17,385 | $931k | 43.0% | Unusual | SEC |
| Mar 5, 2024 | Mar 5, 2024 | KOP | VP, Zero Harm | Form 144 notice | 13,897 | $744k | Notice | SEC | |
| Mar 4, 2024 | Mar 4, 2024 | KOP | VP, Zero Harm | Form 144 notice | 3,488 | $187k | Notice | SEC | |
| Mar 1, 2024 | Mar 5, 2024 | KOP | VP, Zero Harm | Form 4 sale | 14,500 | $774k | 28.2% | Unusual | SEC |
| Mar 1, 2024 | Mar 1, 2024 | KOP | VP, Zero Harm | Form 144 notice | 14,500 | $774k | Notice | SEC | |
| Dec 14, 2023 | Dec 15, 2023 | KOP | VP, Zero Harm | Form 4 sale | 2,600 | $118k | 6.9% | No plan | SEC |
| Dec 14, 2023 | Dec 14, 2023 | KOP | VP, Zero Harm | Form 144 notice | 2,600 | $118k | Notice | SEC | |
| Nov 17, 2023 | Nov 20, 2023 | KOP | VP, Zero Harm | Form 4 sale | 5,250 | $223k | 12.2% | No plan | SEC |
| Nov 17, 2023 | Nov 17, 2023 | KOP | VP, Zero Harm | Form 144 notice | 5,250 | $223k | Notice | SEC | |
| Jun 6, 2023 | Jun 8, 2023 | KOP | Global VP, Zero Harm | Form 4 sale | 15,265 | $480k | 28.8% | Unusual | SEC |
| Jun 6, 2023 | Jun 6, 2023 | KOP | VP, Zero Harm | Form 144 notice | 15,262 | $480k | Notice | SEC | |
| Feb 28, 2022 | Mar 2, 2022 | KOP | Global VP, Zero Harm | Form 4 sale | 1,749 | $50k | 5.2% | Plan not stated | SEC |
| Feb 28, 2022 | Mar 1, 2022 | KOP | Global VP, Zero Harm | Form 4 sale | 3,000 | $86k | 8.2% | Plan not stated | SEC |
| May 30, 2018 | May 31, 2018 | KOP | Global VP, SHE & Process Excel | Form 4 sale | 10,887 | $438k | 44.2% | Unusual | SEC |
| May 23, 2018 | May 24, 2018 | KOP | Global VP, SHE & Process Excel | Form 4 sale | 5,665 | $230k | 23.9% | Plan not stated | SEC |